| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Series A, Series B, Series C, Pre-IPO |
Integra Holdings is an investment fund that specializes in transforming academic innovation in the life sciences sector into successful market ventures.
They are the exclusive gateway for investments in early-stage research and technologies coming out of Hebrew University, one of Israel's foremost research institutions. The firm focuses on a carrying and personal approach to investments, intending to craft success stories by navigating academic ideas through to the business world.
Integra Holdings has the unique benefit of having exclusive access to review, evaluate, and invest in life sciences research from Hebrew University. This allows them to handpick the most promising innovations in fields such as Pharmaceutical Biotechnology, Medical Devices, Diagnostics, and Artificial Intelligence.
Their investment stages range from Series A to Pre-IPO, which reflects their commitment to supporting companies throughout multiple growth phases. The company prides itself on bringing academic excellence to market by fostering a close collaboration with the researchers and entrepreneurs developing these cutting-edge technologies.
This symbiosis ensures a steady flow of innovative products and services poised to create impacts in their respective industries. Integra Holdings' approach is evident in their carefully curated portfolio, which showcases a diverse array of companies representing their strategic investment thesis focused on groundbreaking life science advancements.

